JO, B., LL, R., ET, N., KE, I., M, D., LY, R., . . . SA, W. (2023). Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series. The oncologist, 28(2), 172. https://doi.org/10.1093/oncolo/oyac248
Chicago Style (17th ed.) CitationJO, Brett, et al. "Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series." The Oncologist 28, no. 2 (2023): 172. https://doi.org/10.1093/oncolo/oyac248.
MLA (9th ed.) CitationJO, Brett, et al. "Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series." The Oncologist, vol. 28, no. 2, 2023, p. 172, https://doi.org/10.1093/oncolo/oyac248.